(0)
NEW YORK, NY / ACCESSWIRE / April 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced that the first patient has been dosed in an open-label Phase 2 clinical trial of belumosudil, the Company s ROCK2 inhibitor, in patients with diffuse cutaneous systemic sclerosis (dcSSc), a chronic immune disorder characterized by fibrosis of the skin and internal organs.
The Phase 2 study (KD025-215) will enroll up to 15 adults with dcSSc who will receive orally administered belumosudil 200 mg twice daily (BID). The primary endpoint is the Combined Response Index for Systemic Sclerosis (CRISS) score. The Company plans to present initial data from this study by year-end 2021.
In addition to the KD025-215 trial, an ongoing, double-blind, placebo-controlled Phase 2 clinical trial of belumosudil (KD025-209) is currently enrolling 60 adults with dcSSc. Patients are randomized to receive belumosudil 200 mg once daily (QD), belumosudil 200 mg BID or placebo.
Medicare Supplement Insurance Conference Early Registration Ends Soon From:
Early registration discounts for the National Medicare Supplement Insurance Conference Summit are set to end April 15 reports the American Association for Medicare Supplement Insurance (AAMSI). The early registration rate of $400 will increase to $650 soon, announced Jesse Slome, AAMSI s director and organizer of the industry conference. The industry conference takes place September 8-10, 2021 at the Schaumburg, IL Convention Center located a few miles from O Hare International Airport. The Medicare insurance industry keeps growing and changing as does the industry conference, Slome notes. This year we ve filled a 30,000 square foot exhibit hall with 134 booth space
The American Academy of Sleep Medicine recently published an update on the use of telemedicine for the diagnosis and treatment of sleep disorders to reflect lessons learned from the transition to telemedicine during the COVID-19 pandemic and the benefits of continuing to utilize remote care when appropriate.
Roughly 70% percent of individuals age 65 or older have now received their first Covid shot, and 43% are fully vaccinated, according to the Centers for Disease Control and Prevention. As more of the population becomes inoculated against the virus, travel is again on the minds of people who have hunkered down for the last year.
Here s what to know about the differences in Medicare coverage away from home.
The nitty gritty
Basic, or original, Medicare consists of Part A (hospital coverage) and Part B (outpatient care). Individuals who choose to stick with that coverage instead of going with an Advantage Plan typically pair it with a stand-alone prescription-drug plan (Part D).